Johnson & Johnson said it had temporarily stopped clinical trials of a candidate vaccine for Covid-19 disease after one of the participants contracted an unexplained disease, delaying one of the most important efforts made to contain the global pandemic. The company said in a statement on Monday that an independent board to monitor data and … Read more
Jakarta, CNBC Indonesia – There’s good news about vaccines Covid-19 concoction of the company from the United States (US) Johnson & Johnson. Preliminary results from phase 2 clinical trials indicate that this vaccine is well tolerated. Even one dose appears to produce a strong immune response in nearly all of the 800 people. The trial … Read more
Johnson & Johnson announced that the covid-19 vaccine it is manufacturing produces a strong immune response in just one dose. Called Ad26.COV2.S, the vaccine was also well tolerated when administered in two doses, shows the trial that is in an intermediate phase. However, it has not been proven to be effective in protecting the elderly, … Read more